Description
SeaBeLife is a biotechnology company that develops drug candidates to block cellular necrosis in order to protect or regenerate major organs affected by severe pathologies.
See the website
Case studies
VISIBILITY AND MARKET RECOGNITION FOR INNOVATIVE BIOTECH STARTUP
After receiving €1.37M from Bpifrance, SeaBeLife, a French biotech company developing drug candidates intended to block cell necrosis, wished to increase its visibility and gain market recognition.Read more